NexGel Inc Common Stock Earnings Recaps
Q3 2025
Nov 12, 2025
NEXGEL reported stable revenue of $2.9 million in Q3 2025 with improved gross profit margins and a narrowing adjusted EBITDA loss, reflecting operational efficiencies and strong demand in contract manufacturing.
Key takeaways
- Contract manufacturing revenue reached $907,000, supported by strong partnerships, particularly with Cintas for wound care kits.
- Adjusted EBITDA loss narrowed to $354,000, showing improvement from previous quarters.
- Consumer brand segment remains stable, with new product launches anticipated to drive sales growth in Q4, including Silly George's lip gloss and Kenco Derm's eczema solutions.
- Strategic partnership with Stada expanded to include new product launches aimed at the North American market, backed by significant non-dilutive financing.